Fluoink Nanotechnologies, a pioneering Tunisian startup, was founded in 2022 by four distinguished scientists from the Faculty of Sciences of Sfax: Ramzi Maalej, Fakher Chabchoub, Marwa Abid, and Hanen Douiri. With a vision to revolutionize the disinfection and sterilization landscape through cutting-edge nanotechnology, Fluoink has quickly positioned itself as a leader in the field, offering innovative solutions for a wide range of applications.
Founders’ Backgrounds
- Ramzi Maalej, PhD: A Professor of Physics at the University of Sfax, Dr. Maalej brings over 22 years of experience in materials science, nanotechnology, photonics, and theoretical simulations. As the leader of a research team of 12 researchers, he has authored over 90 articles, contributed to three book chapters, and holds six national and international patents.
- Fakher Chabchoub, PhD: A Professor of Chemistry at the University of Sfax, Dr. Chabchoub has 24 years of experience in paints and pigments. As a master coordinator, he has published more than 80 papers, adding substantial expertise in chemistry and material sciences to the team.
- Marwa Abid, PhD: Dr. Abid, a chemist with over 10 years of experience in nanotechnology, has been instrumental in the development of innovative applications of nanomaterials.
- Hanen Douiri, PhD: Dr. Douiri, a physicist with more than 10 years of experience in materials science, design, fabrication, and simulations, completes the team with her deep knowledge of physical sciences.
Products and Innovations
Bacticleaner Platform
Fluoink's flagship product, the Bacticleaner platform, is a groundbreaking solution that harnesses state-of-the-art nanotechnologies to sanitize a variety of surfaces. These include paints, wood, devices, glass, and textiles. Bacticleaner ensures a germ-free environment by eradicating 99.9% of even the most resistant bacteria and viruses, offering efficient and durable protection against infections and pandemics. The platform’s unique selling proposition lies in its ability to integrate advanced antimicrobial properties with environmentally friendly technologies, making it suitable for a broad spectrum of applications, from healthcare facilities to recreational areas and residences.
Recent Achievements
Recently, Fluoink installed its first production unit for the Bacticleaner platform, marking a significant milestone in its journey. The first quantities are expected to be delivered in September 2024 to three paint companies, demonstrating the scalability and demand for their innovative solutions.
Market Opportunities and Strategy
Expansion into the International Markets
Fluoink Nanotechnologies is strategically expanding into the internationa market, leveraging its patent protection, the presence of existing talents , and participation in acceleration programs (Labinnova2024) and big events (SelectUSA) to navigate this new terrain. The U.S. market offers vast potential for growth and innovation, with a high demand for advanced antimicrobial solutions. Establishing a presence in the U.S. will allow Fluoink to tap into new opportunities, forge strategic partnerships, and access cutting-edge research and development capabilities.
Impact and Contributions
Expanding into the international market will not only benefit Fluoink but also contribute to economic growth in Tunisia by creating job opportunities, fostering technological innovation, and enhancing the country's reputation as a hub for scientific excellence and innovation. The startup's green-tech disinfectant solutions align with several United Nations Sustainable Development Goals (SDGs), including Good Health and Well-being, Industry, Innovation, and Infrastructure, and Responsible Consumption and Production.
Competitive Landscape
In the antibacterial paint market, Fluoink stands out due to its patented technology, scalable production, competitive pricing, and continuous R&D activities. The company’s innovative approach and advanced nanotechnology solutions position it ahead of competitors who primarily rely on traditional methods.
Business Model and Growth
Fluoink’s business model revolves around delivering high-quality nanotechnology-based disinfectant solutions to various industries. The company achieves sales through strategic partnerships and direct engagements with industry leaders. Existing customers include paint companies and healthcare facilities, with a growing list of clients as demand for their products increases. The company will sign memorandums of understanding (MoUs) with multiple companies, reinforcing its promising plan for expansion.
Funding and Financial Needs
To date, Fluoink has secured approximately $1.5 million in grants from national and international R&D projects. As the company scales, it seeks additional funding to expand production capabilities, enhance R&D activities, and strengthen its market presence. Fluoink is raising funds to support these objectives, ensuring sustainable growth and innovation.
